Transcriptome-based high-frequency recurrence index predicts frequent recurrence in non-muscle-invasive bladder cancer after Bacillus Calmette-Guérin therapy
HfRI represents a robust, transcriptome-based tool for predicting frequent recurrence in NMIBC patients. The HfRI supports earlier identification of patients at risk of high-frequency recurrence, thereby supporting personalized treatment strategies.
Authors
- Seok Joong Yun (ORCID: https://orcid.org/0000-0001-7737-4746)
- WUN-JAE KIM
- Seon-Kyu Kim
- Jee-Woo Seo
- Seung-Woo Baek (ORCID: https://orcid.org/0000-0003-4664-4162)
- Young Deuk Choi (ORCID: https://orcid.org/0000-0002-8545-5797)
- Otabek Kamarov
- Seongmin Moon (ORCID: https://orcid.org/0009-0003-7090-5067)
- Sung-Kwon Moon
- Yung Hyun Choi
- Seon-Young Kim
- Xuan-Mei Piao
- Young Joon Byun
- Il-San Jeong
- Ho Won Kang
- Won Tae Kim
- Kyeong Kim
Institutions
- Chungbuk National University (KR)
- Yonsei University (KR)
- Dong-Eui University (KR)
- Hanil General Hospital (KR)
- Chungbuk National University Hospital (KR)
- Dankook University Hospital (KR)
- Chung-Ang University (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Korea University of Science and Technology (KR)
Publication Details
- Journal
- BMC Medicine
- Published
- 2026-02-27
- DOI
- https://doi.org/10.1186/s12916-026-04745-8
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00